ID   DF15
AC   CVCL_Y429
DR   Wikidata; Q54831023
RX   Patent=US20070027175;
RX   PubMed=22552008;
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
RX   Patent=US20070027175;
RA   Shaughnessy J.D. Jr., Tian E.-M.;
RT   "Antineoplastic activities of ellipticine and its derivatives.";
RL   Patent number US20070027175, 01-Feb-2007.
//
RX   PubMed=22552008; DOI=10.1038/leu.2012.119;
RA   Lopez-Girona A., Mendy D., Ito T., Miller K., Gandhi A.K., Kang J.,
RA   Karasawa S., Carmel G., Jackson P., Abbasian M., Mahmoudi A.,
RA   Cathers B., Rychak E., Gaidarova S., Chen R., Schafer P.H., Handa H.,
RA   Daniel T.O., Evans J.F., Chopra R.;
RT   "Cereblon is a direct protein target for immunomodulatory and
RT   antiproliferative activities of lenalidomide and pomalidomide.";
RL   Leukemia 26:2326-2335(2012).
//